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Abstract
Background: Smad4 mutant embryos arrest shortly after implantation and display a characteristic
shortened proximodistal axis, a significantly reduced epiblast, as well as a thickened visceral
endoderm layer. Conditional rescue experiments demonstrate that bypassing the primary
requirement for Smad4 in the extra-embryonic endoderm allows the epiblast to gastrulate. Smad4-
independent TGF-β signals are thus sufficient to promote mesoderm formation and patterning. To
further analyse essential Smad4 activities contributed by the extra-embryonic tissues, and
characterise Smad4 dependent pathways in the early embryo, here we performed transcriptional
profiling of Smad4 null embryonic stem (ES) cells and day 4 embryoid bodies (EBs).
Results: Transcripts from wild-type versus Smad4 null ES cells and day 4 EBs were analysed using
Illumina arrays. In addition to several known TGF-β/BMP target genes, we identified numerous
Smad4-dependent transcripts that are mis-expressed in the mutants. As expected, mesodermal cell
markers were dramatically down-regulated. We also observed an increase in non-canonical
potency markers (Pramel7, Tbx3, Zscan4), germ cell markers (Aire, Tuba3a, Dnmt3l) as well as early
endoderm markers (Dpp4, H19, Dcn). Additionally, expression of the extracellular matrix (ECM)
remodelling enzymes Mmp14 and Mmp9 was decreased in Smad4 mutant ES and EB populations.
These changes, in combination with increased levels of laminin alpha1, cause excessive basement
membrane deposition. Similarly, in the context of the Smad4 null E6.5 embryos we observed an
expanded basement membrane (BM) associated with the thickened endoderm layer.
Conclusion: Smad4 functional loss results in a dramatic shift in gene expression patterns and in
the endodermal cell lineage causes an excess deposition of, or an inability to breakdown and
remodel, the underlying BM layer. These structural abnormalities probably disrupt reciprocal
signalling between the epiblast and overlying visceral endoderm required for gastrulation.
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Background
Members of the TGF-β super-family of secreted growth
factors activate a cell surface receptor complex comprised
of two distinct transmembrane serine/threonine kinases
that, upon ligand binding, phosphorylate members of the
downstream receptor-associated Smads (R-Smads)
(reviewed by [1]). The closely related R-Smads, Smad2
and Smad3 are phosphorylated in response to TGF-β s,
Activin and Nodal signals. Smad1, Smad5 and Smad8
transmit BMP and GDF signals. The phosphorylated R-
Smads in association with the common mediator Smad,
Smad4, recruit additional cofactors to form higher order
complexes that regulate target gene expression (reviewed
by [2]). Smad4, originally discovered as a tumour sup-
pressor gene, shares overall structural features with the R-
Smads. However, its MH2 domain lacks the C-terminal
SXS motif required for receptor-mediated phosphoryla-
tion. Smad4-RSmad complexes control a diverse array of
biological processes, including cell proliferation, differen-
tiation and cell survival during development and adult tis-
sue homeostasis.
In the early embryo, reciprocal signalling between the epi-
blast, extra-embryonic ectoderm (ExE) and the overlying
visceral endoderm (VE) is responsible for axis patterning
and specification of the germ layers (reviewed by [3,4]).
Members of the TGF-β/Nodal and BMP subfamilies act as
morphogens that control cell differentiation in a concen-
tration dependent manner. Nodal signals from the epi-
blast promote the formation of the distal visceral
endoderm (DVE) [5,6]. This specialised cell population
migrates anteriorly to become the anterior visceral endo-
derm (AVE) [7]. Expression of the Nodal antagonists
Lefty1 and Cer1 by the AVE, is essential for patterning the
underlying anterior epiblast [8]. On the posterior side of
the embryo, BMP signals from the ExE together with
Nodal signals from the epiblast promote primitive streak
formation and mesoderm induction [9-12]. Continued
Nodal signalling during gastrulation instructs epiblast
cells passing through the anterior primitive streak to
become definitive endoderm, prechordal plate, node and
notochord [13]. Signalling via the BMP pathway is also
crucial in early embryonic development (reviewed by
[14,15]). Genetic studies demonstrate that activities of
closely regulated R-Smads modulate dose-dependent
Nodal and BMP signals in the early embryo [11,16].
Smad4 null embryos arrest shortly after implantation due
to defects in the extra-embryonic lineages [17-19]. The
mutants have a shortened proximodistal (P-D) axis, fail to
acquire initial anterior-posterior (A-P) polarity, cannot
gastrulate and are severely disorganised by E6.5. Early
studies attributed the lethality to global proliferative
defects [17,18] but conditional rescue experiments dem-
onstrate that TGF-β signalling pathways in the embryo
proper are surprisingly Smad4-independent [19]. Thus
mutant epiblasts, in response to cues from wild-type
extra-embryonic tissues, are able to gastrulate and gener-
ate diverse mesodermal derivatives [17,19], including the
allantois, a rudimentary heart and mid-streak derivatives
such as the somites and lateral plate mesoderm. Thus,
early A-P axis formation and mesodermal patterning are
unaffected. However, Smad4 is required for specification
of the anterior primitive streak (APS) derivatives includ-
ing the prechordal plate, node, notochord and definitive
endoderm. Smad4 is also essential for BMP-dependent
primordial germ cell (PGC) formation [19].
To investigate Smad4 requirements at early stages of
embryonic development, here we exploited Smad4 null
ES cells in transcriptional profiling experiments. We com-
pared gene expression patterns in undifferentiated wild-
type and mutant ES cells as well as embryoid bodies (EBs).
The list of up- or down-regulated genes includes several
previously described TGF-β/BMP/Smad targets. As
expected, Smad4 mutant EBs show a marked decrease in
gastrulation markers. The mutants display increased
expression of several non-canonical potency markers,
germ cell markers and early endoderm markers. Interest-
ingly, Smad4 functional loss results in increased laminin
expression and decreased expression of matrix metallo-
proteinases (Mmps). Mutant EBs display thickened endo-
derm, an expanded basement membrane layer and exhibit
defective migratory properties. Collectively these results
demonstrate that Smad4-dependent transcriptional regu-
lation controls development of the extra-embryonic endo-
derm cell lineage.
Results
Transcriptional profiling of Smad4 null ES cells and EBs
To identify developmentally regulated transcripts that are
potentially mis-regulated in the absence of Smad4, we
analysed ES cells grown in the presence of LIF, or induced
to differentiate as EBs in suspension culture. We com-
pared mRNA expression patterns of wild-type and Smad4
null ES cells and day 4 EBs using the Illumina array plat-
form. We utilised two independent 129S9/SvEvH wild-
type (CCE/CCB) [20] and Smad4 null (FNN/BNN) ES cell
lines [19]. After 4 days of suspension culture the outer
cells of EBs are induced to differentiate to form a layer of
primitive endoderm, while a sub-population of inner cells
express nascent mesodermal markers. These cell aggre-
gates closely resemble and share many characteristics of
E6.5 embryos, the stage when growth defects become evi-
dent in Smad4 null mutants. Genes that displayed a 1.5
fold change and a statistical significance to p < 0.01 (cor-
rected for multiple testing) were considered as differen-
tially expressed. In Smad4 null ES cells, 243 probe sets
detected transcripts up-regulated and 424 down-regu-
lated, while in the EBs 674 and 464 probe sets detectedBMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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increased and decreased transcript expression, respec-
tively. Representative results are summarised in Table 1
and Table 2. The complete list of the mis-regulated genes
is available in Additional Files 1 and 1. Data from the
micro-arrays was validated using quantitative real-time
PCR (Q-PCR) and analysed using the ΔΔCT method [21].
Numerous components of the TGF-β pathway are mis-reg-
ulated in Smad4 deficient cells including ligands (Gdf1,
Tgfb2, Lefty1/2), as well as known target genes (Id1/2/3
and Msx1) (Table 1). The Id family of proteins regulate
cell proliferation and differentiation in response to BMP
signals [22,23]. Id1, Id2 and Id3 are selectively down-reg-
ulated in cardiac neural crest cells in conditional Smad4
mutants [24]. Up-regulated Id gene expression in
response to BMP signalling is required to sustain self-
renewal and pluripotency under serum-free conditions
[25]. Here, loss of Smad4 function in ES cells and EBs
results in reduced expression of Id1, Id2 and Id3 family
members (Table 1). Western blots similarly reveal that Id1
protein levels are reduced by roughly 7-fold (Figure 1A).
Expression of Msx1, a Bmp responsive transcription factor,
previously identified as a Bmp4 target in ES cells [26], is
also down-regulated (Table 1;[19]). The Lefty proteins act
as competitive inhibitors of Nodal and antagonise signal-
ling via interactions with Nodal, as well as EGF-CFC co-
receptors such as Cripto [27,28]. Lefty 1 and Lefty 2 expres-
sion is activated in response to Nodal/Activin signals
[29,30]. Here we observe decreased Lefty1  and  Lefty2
expression levels due to loss of Smad4 (Table 1). Collec-
tively these results demonstrate that Smad4 controls
expression of several known TGFβ/BMP target genes and
suggest that this array platform offers a promising
approach to characterise Smad4-dependent transcrip-
tional networks that regulate early embryonic develop-
ment.
Increased steady state levels of phosphorylated receptor 
Smads
Smad4 deficient pancreatic carcinoma cell lines express
increased levels of phosphorylated Smad2 (P-Smad2)
[31]. However, in contrast, P-Smad2 levels were unaf-
fected by Smad4 knock down in HaCaT cells [32]. We
decided to compare basal TGF-β/BMP signalling in wild-
type and Smad4 mutant ES cells. As shown in Figure 2,
wild-type (CCE & CCB) and Smad4 null ES cells (FNN &
BNN) express roughly equivalent steady-state levels of
Smad2/3. However under normal culture conditions, in
the absence of exogenous TGF-β ligands, Smad4 mutant
ES cells constitutively express 2-2.5 fold more phospho-
Smad2 in comparison with wild-type (Figure 2A). Simi-
larly, loss of Smad4 has no effect on steady-state levels of
effectors of the Bmp pathway, Smad1 and Smad5. How-
ever, we observed increased levels of P-Smad1/5/8 R-
Smads (Figure 2B). Thus Smad4 loss results in increased
phosphorylation of both categories of R-Smads. In con-
trast, phosphorylated Erk1/2 levels remain unchanged in
the absence of Smad4 expression (Figure 2B).
Mis-expression of non-canonical potency genes and germ 
cell markers
Smad4 null E6.5 embryos strongly express Oct4 [19].
Consistent with this, expression levels of the canonical
core stem cell markers, Oct4, Nanog and Sox2 are unaf-
fected in Smad4 mutant ES cells. However, numerous
early embryonic and stem cell markers, including Pramel7,
Tbx3 and Zscan4, are consistently up-regulated in Smad4
mutant ES cells (Table 2). Pramel7 is normally expressed
at morula stages and is restricted to the inner cell mass of
early blastocysts [33]. Pramel7 over-expression promotes
LIF-independent self-renewal [33]. While transcripts are
barely detectable in WT ES cells [34], Pramel7 expression
increased roughly 6-fold in Smad4 mutant ES cells. Simi-
larly, Tbx3, previously identified as a direct target of BMP
Smads [35], is also up-regulated. Tbx3 plays an essential
role in stem cell self-renewal and enforced expression
represses mesodermal cell lineage commitment [36]. The
zinc finger protein Zscan4 is normally expressed in late 2-
cell embryos and a subpopulation of ES cells [37]. Previ-
ous experiments demonstrate Zscan4 is essential for pre-
implantation development [37] and controls ES cell
pluripotency [38]. Here we observed over 2-fold increased
expression of Zscan4 in both mutant ES cells and EBs.
Rhox5/Pem, an X-linked homeodomain-containing gene,
is up-regulated in mutant EBs. Rhox5  is normally
expressed in morula and early blastocyst stage embryos,
but shortly after implantation expression becomes
restricted to extra-embryonic lineages, specifically the VE
and extra-embryonic ectoderm (ExE) [39]. Interestingly,
Rhox5 is normally expressed in ES cells, but is not detected
in the primitive ectoderm [39] and Rhox5 over-expression
inhibits ES cell differentiation [33,40]. Thus, Rhox5 func-
tion maintains early stem cell populations and promotes
development of the extra-embryonic cell lineages. Collec-
tively these results demonstrate that Smad4-dependent
signalling regulates expression of potency genes.
Germ cell specification in response to BMP/Smad signals
is strictly Smad4-dependent. Interestingly, expression of
several germ cell markers was increased (Table 2). E2F6,
which associates with polycomb group complexes, plays
an important role in repressing meiosis-specific genes,
including Tuba3a and Smc1  [41,42]. These E2F6 target
genes are also mis-expressed in Smad4 deficient cells.
These results strengthen the idea that Smad4-dependent
signals regulate transcriptional networks upstream of
early cell fate decisions.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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Table 1: Down-regulated genes in Smad4 null ES cells and/or day 4 embryoid bodies
Down-regulated Embryonic Stem Cell Array Day 4 Embryoid Body Array
Gene ID Gene Description RefSeq Chr ES Array Fold 
Change
Q-PCR data 
Fold Change
P-value EB Array Fold 
Change
Q-PCR data 
Fold Change
P-value
Tgf-beta pathway
Id1 Inhibitor of DNA 
binding 1
NM_010495 2 9.2 8.43 ± 2.09 0.013 7.4 23.3 ± 4.14 0.0017
Id2 Inhibitor of DNA 
binding 2
NM_010496 12 3.8 7.23 ± 2.32 0.1193 1.7 n.d. n.d.
Id3 Inhibitor of DNA 
binding 3
NM_008321 4 2.8 3.13 ± 0.72 0.0279 1.8 n.d. n.d.
Gdf1 Growth differentiation 
factor 1
NM_008107 8 4.0 3.73 ± 0.18 <0.0001 1.75 4.01 ± 0.56 0.0018
Lefty2 (Ebaf) Left-right 
determination factor 2
NM_177099 1 3.7 5.47 ± 1.18 0.0096 1.47 n.d. n.d.
Lefty1 Left-right 
determination factor 1
NM_010094 1 1.6 1.77 ± 0.1 0.0004 - n.d. n.d.
Tgfb2 Transforming growth 
factor, beta 2
NM_009367 1 3.0 n.d. n.d. - n.d. n.d.
Msx1 Homeobox, msh-like 1 NM_010835 5 1.7 n.d. n.d. 2.5 n.d. n.d.
Extracellular matrix related
Mmp14 Matrix 
metalloproteinase 14 
(membrane-inserted)
NM_008608 14 4.5 5.44 ± 0.57 0.0002 3.2 5.16 ± 0.85 0.0028
Mmp9 Matrix 
metalloproteinase 9
NM_013599 2 1.6 2.97 ± 0.33 0.001 1.54 1.79 ± 0.28 0.092*
Cd44 CD44 antigen NM_009851 2 2.7 7.25 ± 2.73 0.0625* 1.9 5.28 ± 1.62 0.0409
Tgfb1i1 (Hic5) Transforming growth 
factor beta 1 induced 
transcript 1
NM_009365 7 2.8 7.39 ± 2.54 0.046 2.1 6.26 ± 1.95 0.0357
Gastrulation markers
Gsc Goosecoid homeobox NM_010351 12 - n.d. n.d. 15 7.11 ± 0.79 < 0.0001
Fgf8 Fibroblast growth 
factor 8
NM_010205 19 2.0 n.d. n.d. 14.1 13.85 ± 2.58 0.0006
Sp5 Trans-acting 
transcription factor 5
NM_022435 2 2.4 n.d. n.d. 12 n.d. n.d.
T Brachyury NM_009309 17 2.3 n.d. n.d. 10.6 60.7 ± 8.43 0.0004
Lhx1 LIM homeobox 
protein 1
NM_008498 11 - n.d. n.d. 10.6 n.d. n.d.
MixL1 Mix1 homeobox-like 1 NM_013729 1 - n.d. n.d. 6 13.98 ± 2.93 0.0046
En1 Engrailed 1 NM_010133 1 1.6 n.d. n.d. 4.95 n.d. n.d.
Wnt8a Wingless-related 
MMTV integration 
site 8A
NM_009290 18 - n.d. n.d. 4.4 n.d. n.d.
Sox9 SRY-box containing 
gene 9
NM_011448 11 - n.d. n.d. 3.5 n.d. n.d.
Fgf17 Fibroblast growth 
factor 17
NM_008004 14 2.5 n.d. n.d. 2.4 n.d. n.d.
Wnt9a Wingless-type MMTV 
integration site 9A
NM_139298 11 2.4 n.d. n.d. - n.d. n.d.
Eomes Eomesodermin NM_010136 9 - n.d. n.d. 2.1 8.03 ± 0.67 < 0.0001
Chrd Chordin NM_009893 16 - n.d. n.d. 1.97 n.d. n.d.
Cer1 Cerberus 1 homolog NM_009887 4 - n.d. n.d. 1.91 n.d. n.d.
Foxa2 Forkhead box A2 NM_010446 2 - n.d. n.d. 1.8 8.98 ± 2.55 0.0216
Fgf5 Fibroblast growth 
factor 5
NM_010203 5 - n.d. n.d. 2.16 3.16 ± 0.14 < 0.0001
Igf2 Insulin-like growth 
factor 2
NM_010514 7 3.3 3.9 ± 0.72 0.0078 1.7 n.d. n.d.
Micro-array and Q-PCR results are presented as fold change ratios relative to normalised wild-type values. The ES array results denote the average fold change of the two 
independent null cell lines. Genes with a 1.5 fold decrease were considered as differentially expressed. Q-PCR data is displayed as the mean ± standard error of the mean 
(SEM) of mRNA expression levels relative to Hprt. Genes validated by Q-PCR are significantly differentially expressed (p < 0.05), except for those indicated by an asterisk. n.d. 
validation not determined. A subset of differentially expressed transcripts is shown. * indicates higher than 0.05 P value for Q-PCR validation.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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Smad4 mutant ES cells display increased expression of 
early endoderm markers
Smad4 loss results in increased expression of several
endoderm specific markers (Table 2). For example, Dpp4
expression increased by roughly 3-fold. Dpp4 is normally
activated in the VE shortly after implantation and is unde-
tectable in the epiblast and undifferentiated wild-type ES
cells [43]. Similarly, Dab2 is expressed in the VE and is
required for surface sorting and positioning of endoderm
cells [44,45]. Dab2 expression was increased in Smad4
mutant ES cells. Dab2 is a downstream target of Gata6
[46], a well-characterised endoderm marker [47,48]. Q-
PCR shows roughly an 8 fold-increase in Gata6 levels in
one of the Smad4 null ES cell lines (Table 2). H19, an
imprinted gene that is normally expressed in the endoder-
mal lineage [49], as well as Decorin, another endoderm
marker, both show increased expression (Table 2). These
results suggest that signalling cues responsible for guiding
early endoderm development are substantially changed in
the absence of Smad4.
Dramatically decreased expression of gastrulation stage 
markers
Smad4 null embryos arrest at E6.5, fail to acquire initial
anterior-posterior polarity and lack expression of nascent
mesoderm markers. Previous studies described decreased
expression of T  (nascent mesoderm marker) and Hnf4
(primitive endoderm marker) at early stages of EB differ-
entiation [17,19]. Conditional rescue experiments dem-
onstrate that Smad4 is non-essential for mesoderm
formation and patterning, but is required for develop-
ment of the anterior primitive streak (APS) and its deriva-
tives [19]. Here we detect a dramatic down-regulation of
primitive streak markers in Smad4 null EBs (Table 1).
Besides T, we also observe down-regulated expression of
the Nodal targets (Gsc and Foxa2), as well as APS markers
(Gsc, Lhx1 and Foxa2).
Smad4-dependent pathways regulate expression of extra-
cellular matrix components
Smad4 null ES cells and EBs also display decreased expres-
sion of several extracellular matrix (ECM) related genes
(Table 1). Hic-5, also known as Tgfβ1i1, initially identi-
fied due to its TGF-β- and hydrogen peroxide-inducible
expression [50], is a homolog of the multi-domain pro-
tein paxillin. Both Hic-5 and paxillin localise to focal
adhesion sites and interact with the focal adhesion kinase
(FAK) [51]. These membrane sub-compartments, where
integrin clusters form, link the actin cytoskeleton with the
ECM and are essential to mediate intracellular signalling.
FAK phosphorylates paxillin to provide additional dock-
ing sites for downstream adaptor molecules that collec-
tively regulate cell migration. In NIH 3T3 cells, Hic-5
competes with paxillin and inhibits paxillin phosphoryla-
tion [52]. Hic-5 also controls cell spreading and functions
as a regulator of epithelial-to-mesenchymal transition
(EMT) [52,53]. Here we observed decreased Hic-5 expres-
sion (Figure 1B) and conversely, as predicted, increased
levels of phospho-paxillin in Smad4 null ES cells (Figure
1C).
Smad4 loss results in defective endoderm migration during 
EB differentiation
Loss of Smad4 leads to increased expression of the ECM
component laminin alpha1 (Table 2). ECM proteins regu-
late parietal endoderm differentiation and migration in
EB outgrowth assays, in a fibronectin-dependent manner
[54]. To directly test possibly impaired migratory abilities
of Smad4 mutant endodermal derivatives, EBs grown in
suspension were plated on fibronectin and allowed to
attach and spread. Outgrowth and migration of Smad4
deficient EBs was dramatically reduced compared to wild-
type (Figure 3A). Morphometric analysis revealed that
migration decreased by roughly 50% (Figure 3B). Moreo-
ver, Smad4 mutant EB cultures grown in the absence of
LIF for 6 days contain a substantial number of compact
highly adherent cells expressing Oct4 (Figure 3C), a well-
characterised pluripotency marker [55,56]. Thus, Smad4
is required to down-regulate expression of non-canonical
early potency markers/transcription factors such as
Zscan4, Rhox5 and Tbx3 (Table 2), while promoting the
pathways responsible for endoderm formation.
Smad4 functional loss causes defective ECM remodelling
Smad4 mutant ES cells and EBs also express decreased lev-
els of matrix-metalloproteinases (Mmps), notably Mmp14
and  Mmp9  (Table 1). Mmp14 is a membrane-tethered
enzyme, while Mmp9 is secreted [57]. Mmp14 is consid-
ered as a master Mmp because it promotes activation of
additional Mmps [58]. Mmp-mediated degradation of the
ECM allows cells to migrate and also releases biologically
active ligands, including TGF-βs, from the ECM [57].
Reduced Mmp14 expression has been described in Smad4
null neural crest derived cells [24], whereas, Mmp9 was
previously identified as a Smad2/3 target gene in HaCaT
cells [59].
The present findings that Smad4 loss results in decreased
Mmp9 and Mmp14 expression suggest that endodermal
migration may potentially reflect an inability to break-
down and remodel the ECM. To evaluate this possibility,
next we examined EB outgrowths for expression of the
basement membrane components laminin and collagen
IV. As shown in Figure 4A, Smad4 mutant outgrowths dis-
play a striking increase in extracellular deposition of base-
ment membrane components. Laminin and collagen IV
expression is readily detectable in wild-type cells, but is
strongly up-regulated in the absence of Smad4 (Figure 4 &
Additional file 3). Laminin alpha1 transcripts are also up-
regulated (Table 2). Increased production of ECM pro-BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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teins, in combination with reduced levels of ECM degrad-
ing enzymes, thus results in enhanced deposition of
basement membrane components and decreased migra-
tion across the fibronectin substrate. Similarly, increased
levels of laminin and collagen IV expression and hence an
enlarged basement membrane underlying the outer layer
of primitive endoderm was detected in Smad4 mutant EBs
(Figure 4B & Figure 5). Additionally, the outer endoderm
layer was thicker and strongly positive for Dab2 and the
mutant EBs were smaller than the WT controls overall
(Figure 5). Thus the differences initially detectable in early
day 4 EBs continued throughout the differentiation proc-
ess (Figure 4B & Figure 5). The excess production of lam-
inin alpha1 in combination with reduced expression of the
ECM degrading enzymes Mmp14 and Mmp9 (Table 1) dis-
rupts migration and signalling by the Smad4 mutant
endoderm.
Smad4 mutant embryos contain an excessive embryonic 
basement membrane
To examine whether similar changes contribute to the
mutant phenotype in vivo, we analysed Smad4 null
embryos. As expected, the VE is distinctly thicker and the
epiblast is significantly reduced in embryos lacking
Smad4 (Figure 6) [17-19]. Previously published H&E sec-
tions clearly show a thickened single endoderm layer [19].
Interestingly as shown in Figure 6A we observe a marked
increase in collagen IV staining between the epiblast and
visceral endoderm layer. As shown above, mutant endo-
dermal cell populations display increased deposition of
basement membrane that probably leads to a complete
block of reciprocal signalling between the extra-embry-
onic endoderm and epiblast.
Table 2: Up-regulated genes in Smad4 null ES cells and/or day 4 embryoid bodies
Up-regulated Embryonic Stem Cell Array Day 4 Embryoid Body Array
Gene ID Gene Description RefSeq Chr ES Array 
Fold Change
Q-PCR data 
Fold Change
P-value EB Array Fold 
Change
Q-PCR data 
Fold Change
P-value
Early ICM or ES markers
Pramel7 Preferentially expressed 
antigen in melanoma like 7
NM_178250 2 6.0 6.96 ± 1.09 0.002 - n.d. n.d.
Calcoco2 
(Ndp52l1)
Calcium binding and coiled-
coil domain 2
NM_029755 11 3.0 2.66 ± 0.39 0.0112 1.45 n.d. n.d.
Zscan4 Zinc finger and SCAN domain 
containing 4C
NM_001013765 7 2.45 2.24 ± 0.32 0.0525* 2.1 2.94 ± 0.26 0.0002
Magea8 Melanoma antigen, family A, 8 NM_020020 X 2.325 10.7 ± 0.21 < 0.0001 - n.d. n.d.
Tbx3 T-box 3 NM_011535 5 3.0 2.06 ± 0.48 0.1673* 2.6 3.78 ± 1.08 0.0544*
Pramel4 Preferentially expressed 
antigen in melanoma like 4
NM_001001319 4 2.0 5.26 ± 0.58 0.0212 1.5 n.d. n.d.
Germ cell markers
Tuba3a Tubulin, alpha 3A NM_009446 6 4.8 5.76 ± 0.74 0.0013 4.1 5.46 ± 0.87 0.0024
Dnmt3l DNA (cytosine-5-)-
methyltransferase 3-like
NM_019448 10 - n.d. n.d. 3.7 4.43 ± 0.73 0.0038
Smc1b 
(Smc1l2)
Structural maintenance of 
chromosome 1b
NM_080470 15 5.7 n.d. n.d. 2.8 n.d. n.d.
Dazl Deleted in azoospermia-like NM_010021 17 3.1 n.d. n.d. 1.5 n.d. n.d.
Aire Autoimmune regulator NM_009646 10 2.8 5.11 ± 0.91 0.0056 4.1 5.03 ± 1.15 0.0139
Wdr20b WD repeat domain 20b NM_027614 12 2.6 n.d. n.d. 1.45 n.d. n.d.
Endoderm markers
Dpp4 Dipeptidylpeptidase 4 NM_010074 2 2.8 n.d. n.d. 3.8 2.52 ± 0.35 0.0111
H19 H19 fetal liver mRNA NR_001592 7 2.1 1.58 ± 0.08 0.0049 2.7 3.81 ± 0.09 < 0.0001
Dab2 Disabled homolog 2 NM_023118 15 1.8 n.d. n.d. - n.d. n.d.
Dcn Decorin NM_007833 10 1.6 2.4 ± 0.27 0.0055 1.8 1.98 ± 0.56 0.1521*
Lama1 Laminin, alpha 1 NM_008480 17 - n.d. n.d. 3.9 n.d. n.d.
Hnf4a Hepatic nuclear factor 4, 
alpha
NM_008261 2 - n.d. n.d. 1.48 n.d. n.d.
Gata6 GATA binding protein 6 NM_010258 18 4.0 8.18 ± 1.71 0.0005 - n.d. n.d.
Micro-array and Q-PCR results are presented as fold change ratios relative to normalised wild-type values. The ES array results denote the average fold change of the two 
independent null cell lines. Genes with a 1.5 fold decrease were considered as differentially expressed. Q-PCR data is displayed as the mean ± SEM of mRNA expression 
levels relative to Hprt. Genes validated by Q-PCR are significantly differentially expressed (p < 0.05), except for those indicated by an asterisk. Q-PCR validation for Gata6, 
indicated in bold, was performed using only the FNN Smad4 null ES cell line. A subset of up-regulated genes transcripts is shown. * indicates higher than 0.05 P value for Q-
PCR validation.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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Discussion
Mis-regulated genes identified here in Smad4 mutant ES
cells and those previously characterised in screens analys-
ing Smad4 targets in tumour cell lines show surprisingly
little overlap [32,60,61]. Besides technical issues, such as
the use of different array platforms, this difference proba-
bly also reflects cell type specific gene expression patterns.
We employed Smad4 genetically null cells, whereas previ-
ous studies analysed the consequences of knock-down of
Smad4 using RNAi or profiled tumour cell lines, in all like-
lihood carrying multiple mutations that could potentially
complicate the analysis. Smad4  is broadly expressed in
embryonic and adult tissues. Nonetheless, cellular
responses activated by TGF-β/Nodal/BMP signalling path-
ways are remarkably diverse. Thus it seems likely that
Smad4-dependent targets will be influenced by cell-type
specific partnerships and are highly context dependent.
Previous studies demonstrate that growth characteristics
of Smad4 null ES cells are indistinguishable from wild-
type [17,62]. As judged by Smad2 phosphorylation, TGF-
β/Nodal signalling is constitutively active in undifferenti-
ated ES cells ([63] & this study), but its role in promoting
ES cell self-renewal remains unclear [63,64]. BMP signal-
ling activates the Id family of target genes and is required
to sustain self-renewal and pluripotency of ES cells [25].
Smad4 nucleocytoplasmic shuttling is not required for R-
Smad phosphorylation or nuclear localisation [65]. R-
Smad dephosphorylation and nuclear export is thought to
be required for optimal TGF-β signalling [66,67]. Here we
demonstrate that Smad4 loss leads to increased steady
state levels of both BMP and TGF-β phosphorylated R-
Smads (Figure 7). Enhanced R-Smad phosphorylation
levels potentially reflect decreased dephosphorylation
and/or nuclear export [66,67]. In the absence of Smad4,
R-Smads may be less efficiently recognised by C-terminal
phosphatases and/or actively retained in the nucleus.
Another possibility is that increased levels of phosphor-
ylated R-Smads may be caused by reduced expression of
Nodal antagonists, namely Lefty1 and Lefty2 [27,28]. The
lack of negative feedback regulation may dramatically
shift gene expression patterns. Smad4 conditional dele-
tion in cardiomyocytes results in increased phosphoryla-
tion of Erk1/2 [68] and activation of the MAPK pathway
probably contributes to defective heart development.
Erk1/2 signalling has also been implicated in controlling
the transition of ES cells from self-renewal to differentia-
tion [69]. Here, we observe loss of Smad4 in ES cells has
no effect on phospho-Erk1/2 activity. Increased R-Smad
Western blot analysis of candidate genes mis-regulated in  Smad4 null ES cells Figure 1
Western blot analysis of candidate genes mis-regu-
lated in Smad4 null ES cells. A. Id1 expression levels are 
7-fold lower in Smad4 null (FNN/BNN) cell lysates in com-
parison with wild-type (CCE/CCB) ES cells. Id1 protein levels 
were normalised to β-tubulin expression. HeLa, a human epi-
thelial adenocarcinoma cell line, and the human embryonic 
kidney line, HEK293, were used as positive controls. B. Hic-5 
protein levels are reduced in Smad4 null (FNN/BNN) in 
comparison with wild-type (CCB/CCH) ES cell lysates. C. 
Elevated phospho-Paxillin expression by Smad4 deficient ES 
cells. J558L, a myeloma cell line and embryonic fibroblasts, 
SNH, were used as negative and positive controls, respec-
tively.
Loss of Smad4 expression results in increased phosphoryla- tion of R-Smads Figure 2
Loss of Smad4 expression results in increased phos-
phorylation of R-Smads. A. Western blots of lysates from 
wild-type (CCE & CCB) and Smad4 null ES cells (FNN & 
BNN) were probed with antibodies directed against R-Smads 
Smad2/3 or phospho-Smad2. β-tubulin acts as a loading con-
trol. Steady-state levels of Smad2/3 are unperturbed but P-
Smad2 expression is strongly upregulated in Smad4 null ES 
cells. TGF-β stimulated HepG2 cells were included as a posi-
tive control. B. Similarly P-Smad1/5/8 levels are markedly 
enhanced in Smad4 null ES cells, wheras steady state levels of 
Smad1 and Smad5 are unaffected. Bmp4 treated NIH3T3 
cells were included as a positive control. As judged by 
unchanged P-Erk1/2 levels loss of Smad4 function has no 
detectable effect on Erk signalling.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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phosphorylation in the absence of enhanced MAPK sig-
nalling may also contribute to the changes in transcrip-
tional profiles.
As expected Smad4 mutant ES cells and EBs display dra-
matically reduced levels of nascent mesoderm markers
(e.g. T, Mixl1, Gsc). Additionally, loss of Smad4-depend-
ent signals results in increased expression of non-canoni-
cal stem cell genes, including Pramel7, Zscan4 and Tbx3.
The precise roles played by these potency genes, (notably
Calcoco2, Pramel4, Zscan4), remains ill defined. Pramel4,
Pramel7  and  Calcoco2  were initially identified as Oct-4
related genes [70]. Pramel7 is normally expressed in the
compacted morula and the inner cell mass (ICM) of the
early blastocyst and Pramel7  over-expression results in
LIF-independent self-renewal [33].
Only one ZSCAN4 gene has been identified in humans,
while nine paralogous Zscan4  genes are present in the
mouse genome [37]. Of these, six are known to be
expressed and three of these, namely Zscan4c, Zscan4d and
Zscan4f, encode highly similar proteins [37]. Zscan4d is an
abundant transcript at the 2-cell stage but its expression is
rapidly turned off. Expression of Zscan4c, and to a lesser
extent Zscan4f, is up-regulated in blastocyst outgrowths
and is detectable in a mosaic fashion in ES cultures [37].
Smad4 null embryoid bodies display defects in endoderm migration Figure 3
Smad4 null embryoid bodies display defects in endoderm migration. A. Day 4 wild-type and Smad4 null EBs were 
plated onto fibronectin-coated dishes and cultured for 2 days. At both fibronectin concentrations, outgrowth and migration 
were markedly reduced in Smad4 mutant EBs. B. The surface area of the outgrowths was compared using ImageJ. Smad4 null 
EB outgrowths, plotted as a percentage of the corresponding wild-type, show a reduction in the total surface area of out-
growth. C. Oct4 staining of EBs grown on 25 μg/ml fibronectin for 2 days. In contrast to barely detectable Oct4 levels in wild-
type EB derivatives Smad4 null EBs retain robust expression.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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RNAi knock-down experiments demonstrate that Zscan4
is essential for pre-implantation development [37].
Tbx3 is also required for ES cell proliferation. Enforced
expression results in LIF-independent self-renewal and is
sufficient to repress mesodermal commitment [36]. Simi-
larly, Rhox5 over-expression maintains ES cell self-renewal
in the absence of LIF [33] and inhibits EB differentiation
[40]. Rhox5 is also expressed in the primitive endoderm
but its role in vivo remains unknown. Interestingly, expres-
sion of the autoimmune regulator Aire is also up-regu-
lated in Smad4 mutant cells. Aire is normally expressed in
medullary thymic epithelial cells (MTECs) and in the tes-
tis [71,72]. Aire expression by MTECs induces expression
of Nanog, Oct4, and Sox2, and is required for promiscuous
expression of tissue-restricted antigens [71,73]. These
activities are required for imposing central tolerance and
controlling autoimmunity. Increased Aire expression may
similarly contribute to promiscuous gene expression pat-
terns described here in Smad4 mutant ES cells.
Smad4 mutant ES cells also up-regulate expression of
Dab2, Rhox5 and Hnf4a, which are normally expressed in
the early primitive endoderm [74]. The relatively imma-
ture Smad4 mutant endoderm cells may fail to progress
towards a more differentiated VE state. Consistent with
this idea, the endoderm formed by mutant EBs displays a
distinctive more rounded thicker morphology, similar to
that present in mutant embryos. Additionally, marker
genes normally present in mature VE such as Fgf8, Foxa2,
Cer1, Gsc and Lhx1 are markedly down-regulated. Another
possibility is that these genes are under-represented due to
the block in A-P patterning and/or the failure to induce
mesodermal and definitive endoderm cell lineages. These
observations reinforce the idea that Smad4-dependent
signals are essential in the early primitive endoderm to
promote reciprocal signalling and pattern the underlying
epiblast.
During mouse embryogenesis, the primitive endoderm
generates a layer of BM between the VE and the epiblast
(embryonic BM), while the highly secretory parietal endo-
derm (PE) cell population, in conjunction with the troph-
ectoderm, is responsible for producing Reichert's
membrane, the protective layer between the embryo and
the maternal uterine environment. The BM overlying the
embryo polarises the epiblast and stimulates cavitation
[75]. Numerous mutations that disrupt basement mem-
brane synthesis cause early post-implantation lethality
[76-78]. Mmps play important roles in ECM remodelling,
however their functional contributions to early embry-
onic development remains ill defined. It has been pro-
Increased expression of basement membrane proteins by  Smad4 mutant EB outgrowths Figure 4
Increased expression of basement membrane pro-
teins by Smad4 mutant EB outgrowths. A. Day 4 wild-
type and Smad4 null EBs grown for 2 days on fibronectin-
coated (25 μg/ml) dishes. Smad4 mutant EBs express 
increased levels of laminin. B. Cryosections of day 4, day 7 
and day 10 suspension EBs stained for collagen IV. Smad4 
mutant EBs display progressively increased basement mem-
brane deposition beneath the outer endoderm layer.
Mature Smad4 mutant embryoid bodies display a thickened  endoderm and expanded basement membrane Figure 5
Mature Smad4 mutant embryoid bodies display a 
thickened endoderm and expanded basement mem-
brane. The day 10 Smad4 null EBs strongly express Dab2. 
The thick extracellular matrix, detectable by hematoxylin and 
eosin (H&E) staining, stains positive for both laminin and col-
lagenIV.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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posed that Mmps synthesised by the trophectoderm
promote implantation of the embryo into the uterine wall
[79]. Mmp9 and Mmp2 are known to be expressed by ICM
outgrowths and cultured PE-like cells [80,81]. However,
none of the Mmp loss of function mutations generated to-
date disrupt early development. In all likelihood the fail-
ure to observe embryonic phenotypes simply reflects the
extensive overlapping expression patterns and functional
redundancy among close family members [57,82].
Numerous ECM-related genes, including PAI-1, fibronectin
and pro-collagens, are controlled by Smad4-independent
signals [32,62]. The present experiments demonstrate for
the first time that remodelling ECM components in the
early embryo requires Smad4-dependent signals (Figure
7). Besides breaking down the ECM, Mmps can also
release cell surface associated growth factors from the
ECM. In particular, Mmp2 and Mmp9 release biologically
active TGF-β [83]. Cd44 and TGF-β are known Mmp sub-
strates [83,84] and intriguingly both Cd44 and Tgf- 2 are
mis-regulated in Smad4 mutant ES cells.
Reduced Mmp14 and Mmp9 expression in combination
with up-regulated laminin production, leads to excessive
BM deposition and results in endoderm migration defects
in EB outgrowth assays. Interestingly, previous studies
demonstrate that endodermal derivatives of ES cells, with
a constitutively active Akt/PKB pathway, similarly pro-
duce excess BM underlying the endoderm layer, due to a
massive increase in laminin-1 and collagen IV synthesis
[85]. We speculate that cross-talk between TGF-β and Akt/
PKB signalling pathways may cooperatively regulate
expression and remodelling of ECM components in the
early embryo.
The present results demonstrate that Smad4 mutant endo-
dermal derivatives display defective migration in EB out-
growth assays. Similarly, Smad4 regulates TGF-β induced
cell migration in keratinocytes and pancreatic tumour
cells [32]. The epithelial-mesenchymal transitions essen-
tial in the early embryo and those associated with tumour
progression exhibit striking similarities. Surprisingly little
is known about TGF-β/Smad signals required for guiding
endodermal cell migration at early stages of development.
Smad4 null blastocysts display defective outgrowth [18]
but cell migration and proliferative capabilities are tightly
coupled, making it difficult to distinguish whether Smad4
loss results in migration defects per se or can be explained
due to decreased cell proliferation. Results of the EB out-
growth assays presented here clearly demonstrate that
Smad4 regulates endoderm migratory capabilities in vitro.
However, formation of the parietal endoderm is not
impaired in Smad4 mutant embryos. Thus synthesis of
Reichert's membrane forms normally despite the small
size of the embryo [18]. Rather, loss of Smad function
selectively disrupts VE development, probably due to
impaired reciprocal signalling between the VE and the epi-
blast. Nodal signalling from the epiblast induces the AVE
in the overlying endoderm via a Smad2 dependent path-
way [5]. In turn, activation of key targets in the AVE
including Foxa2, Lhx1, Cer1 and Lefty1 provide important
signalling cues for patterning the epiblast (reviewed by
[4]). The present experiments demonstrate that Smad4
mutant EBs show reduced expression of Cer1, a negative
regulator of TGF-β/BMP signalling, as well as Foxa2 and
Lhx1 (Table 1). Excess basement membrane produced by
Smad4 mutant endoderm likely acts as a reservoir trap for
Visualising defective endoderm in E6.5 Smad4 mutant  embryos Figure 6
Visualising defective endoderm in E6.5 Smad4 
mutant embryos. A. Collagen IV staining of the thickened 
basement membrane (green arrows) in Smad4 null embryos. 
Blue, DAPI nuclear staining. B. The Smad4 mutant epiblast 
strongly expresses Oct4 and is significantly reduced in size. 
C. Schematic of wild-type versus Smad4 null E6.0-E6.5 
embryos. Blue corresponds to endoderm cells, grey repre-
sens the epiblast and green indicates the basement mem-
brane layer.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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biologically active ligands and causes defective cell-cell
communication between the epiblast, visceral endoderm
and extra-embryonic ectoderm.
Conclusion
Our transcriptional profiling experiments have identified
numerous genes that are differentially expressed in Smad4
mutant ES cells and EBs. Analysis of the gene list provides
new insights into the tissue defects in Smad4 mutant
embryos. The failure to down-regulate the non-canonical
potency markers causes defective endodermal cell lineage
commitment. Developmental arrest is associated with
excess basement membrane, resulting from increased pro-
duction of the ECM components and decreased expres-
sion of Mmps required for remodelling (Figure 7). The
thickened BM disrupts reciprocal signalling between the
VE and epiblast. Hence, deregulated expression of Smad4
target genes in the primitive endoderm results in the ina-
bility to form mesoderm and definitive endoderm.
Methods
RNA analysis
Wild-type (CCE & CCB) and Smad4 null (FNN & BNN)
129S9/SvEvH embryonic stem cell lines adapted to grow
under feeder independent conditions were routinely
expanded on gelatin coated tissue culture dishes in
DMEM plus 15% FCS with 1000 units/ml recombinant
LIF (Millipore). Embryoid bodies generated as described
[86] were harvested at day 4 of differentiation. For RNA
isolation, ES cells were seeded at 1 × 106 cells per 6 cm
dish and harvested the next day at 70-80% confluency.
EBs were harvested by centrifugation. Lysates prepared in
RLT buffer (Qiagen) were removed by scraping and
applied to a QIAshredder (Qiagen). RNA from both ES
cells and EBs was isolated using an RNeasy kit (Qiagen)
accordingly to the manufacturer's instructions.
Array
The ES cell Array data was generated in two phases.
Intially two sets of three technical replicates from wild-
Smad4 controls transcriptional progammes in the early embryo Figure 7
Smad4 controls transcriptional progammes in the early embryo. Loss of Smad4 is associated with increased levels of 
phosphorylated R-Smads and a dramatic shift in gene expression patterns. In wild-type cells TGF-β/BMP/Smad pathways regu-
late target gene expression via (a) Smad4-dependent or (b) Smad4-independent mechanisms. In the absence of Smad4, phos-
phorylated R-Smads are efficiently translocated to the nucleus on their own or by interacting with another partner (indicated 
as an orange box). The pink circles indicate transcriptional partners required for activation or repression of genes. Mis-regu-
lated genes in Smad4 mutant cells potentially reflect the loss of Smad4-dependent pathways or could also be due to increased 
Smad4-independent signalling. In Smad4 mutant cells, genes in red are mis-regulated resulting in defective endoderm differenti-
ation and massive deposition of BM components (indicated by green mesh). In Drosophila, components of the BM, namely Col-
lagen IV, are known to modulate BMP signalling in the extracellular space during development [89]. Overall the present results 
demonstrate TGF-β/BMP/Smad signals control expression of the extracellular matrix and reciprocally, BM components fine 
tune Smad signalling.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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type CCE and Smad4 null FNN ES cell lines were collected
one passage apart. In the second phase three independent
technical replicates collected from wild-type CCB and
Smad4 null BNN ES cell lines. Each dataset was analysed
in an identical manner. The EB array was performed in
one phase using two technical replicates of each of all of
the above four cell lines. The Illumina WG-6 Mouse v1
Sentrix BeadArray contains 46,630 unique probe
sequences targetting 34,784 unique RefSeq accession
identifiers and 33,720 gene symbols. Samples were
arranged randomly with respect to the 6 array positions
within each BeadArray. Arrays were scanned according to
manufacturer's instructions and raw intensity data
extracted for each probe type using the software BeadStu-
dio version 3.0.14. Raw signals were subtracted for back-
ground intensities and imported into R statistical scripting
environment http://www.cran.r-project.org. Data was
transformed using a variance stabilisation algorithm as
implement in the BioConductor http://bioconductor.org
package, vsn [87] and quantile normalised. Unsupervised
analysis consisted of hierarchical clustering using eucli-
dean distance and complete linkage. Differentially
expressed probes were identified using the bioconductor
package limma using a univariate linear model containing
a genotype effect. For phase 1 an additional covariate was
added for passage groups. P values were adjusted for mul-
tiple testing using the Benjamini-Hochberg false discovery
rate. Probes were considered differentially expressed rela-
tive to genotype if they meet a P < 0.01 significance after
adjustment for multiple testing.
Probe identifiers were fully annotated using the Mouse-
6_v1_1_11234304_A array manifest. Gene ontology
enrichment analysis was performed using the online
DAVID bioinformatics resources http://
david.abcc.ncifcrf.gov which uses a modified Fisher Exact
test to ascertain whether certain gene functions are
enriched in a specific gene list above what would be
expected through random sampling of the array. The
background frequencies of gene ontology terms were gen-
erated using all identifiers represented on the Illumina
array.
Q-PCR Validation
Array data was validated by quantitative PCR analysis
using a Corbett Rotagene 3000. cDNA was generated
using the Superscript III Kit (Invitrogen) with oligo-dT
primers. One tenth of the product was amplified in a 15
μl SYBRGreen PCR reaction (Qiagen). Cycling conditions
incorporated an initial denaturation step of 15 min at
94°C; 2 × (30 s at 94°C, 1 min at 72°C and 1 min 30 s at
72°C); 2 × (30 s at 94°C, 1 min at 70°C and 1 min 30 s
at 72°C); 30 × (30 s at 94°C, 1 min at 55-62°C and 1 min
30 s at 72°C) followed by a final extension cycle of 5 min
at 72°C. Primer sequences and annealing temperatures
are provided in Additional File 4. Quantification of fold-
changes initially compared both biological replicates and
was further validated using additional technical replicates.
Relative gene expression was deduced using the ΔΔCt
method [21] in comparison with Hprt as the reference. Ct
values of each qPCR reaction were normalised with the
respective Ct values of the Hprt. The fold change was cal-
culated using the formula: Fold change = 2 -(ΔCtgene1-
ΔCtgene2). The resulting fold change is expressed as mean ±
SEM. Statistical analysis was performed using the Prism5
statistic package and the Students T-test.
Western blot analysis
Cell lysates prepared from Smad4+/+  (CCE, CCB) and
Smad4N/N (FNN, BNN) ES cell lines using RIPA buffer
were subjected to SDS-PAGE and transferred onto PVDF
membranes. Membranes were blocked with 5% milk in
TBS-T then incubated in primary antibodies overnight
including rabbit anti-phospho-Smad2 (Cell Signalling
3101L; 1:1000), mouse anti-Smad2/3 (Transduction
610843; 1:500), rabbit anti-β-tubulin (Santa Cruz sc-
9104; 1:1000), rabbit anti-Id1 (Santa Cruz sc-488; 1:500),
rabbit anti-phospho-Smad1/5/8 (Upstate AB3848;
1:1,000). Mouse anti-Smad1 (Santa Cruz sc-7965; 1:200),
goat anti-Smad5 (Santa Cruz sc-7443; 1:200), rabbit anti-
phospho p44/42 MAP kinase (Erk) (Cell Signalling 9101;
1:1000), rabbit anti-phospho-paxillin (Tyr 118) (Cell Sig-
naling 2541; 1:1,000), mouse anti-Hic5 (BD Transduc-
tion 611164; 1:250). Secondary antibodies were donkey
anti-rabbit HRP (Amersham NA934V; 1:2000) and sheep
anti-mouse-HRP (Amersham NA931V; 1:2000). Blots
were developed by chemiluminescence using ECL plus
(Amersham) and quantified using a Bio-Rad GelDoc and
the Quantity one software.
Embryoid body outgrowth and migration assays
Wild-type and Smad4 null d4 EBs were plated in Lab-Tek
chamber glass slides (Nunc) previously coated 25-50 μg/
ml with fibronectin (Sigma), cultured for 2 days, rinsed
with PBS, fixed with 4% paraformaldehyde, washed in
PBS and then permeabilized with 0.3% Triton X-100-PBS
and blocked in 10% FCS, 0.3% BSA, 0.3% Triton X-100 in
PBS for 30 min at room temperature. Slides were then
incubated with primary antibodies as follows, anti-lam-
inin (Sigma, L-9393; 1:200); anti-collagenIV (Chemicon,
AB756P; 1:100) anti-Oct4 (Santa Cruz sc-8628; 1:200).
Slides were incubated with either a goat anti-rabbit IgG or
donkey anti-goat IgG secondary antibody (Alexa Fluor-
488, Molecular Probes; 1in 500) and mounted with
Vectashield mountant containing the nuclear counter-
stain 4',6-diamidino-2-phenylindole (DAPI) (Vector Labs
H-1200). Fluorescent images were captured with a Zeiss
epifluorescence microscope. Morphometric analysis was
carried out using the ImageJ program.BMC Developmental Biology 2009, 9:54 http://www.biomedcentral.com/1471-213X/9/54
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Cryo-sectioning, immunocytochemistry and 
immunohistochemistry
EBs were washed with PBS, fixed in 4% paraformaldehyde
for 30 minutes at room temperature (RT), washed in PBS,
transferred into 7.5% sucrose in PBS for 3 hrs at RT and
then immersed in 15% sucrose in PBS overnight at 4°C.
The sucrose solution was removed, replaced with Tissue-
Tek O.C.T. compound and samples transferred into a cryo
mould and frozen in an iso-pentane bath on dry ice. 7 μm
cryosections were collected onto gelatin coated positively
charged Superfrost glass slides and were stained with pri-
mary antibodies: anti-laminin (Sigma, L-9393; 1:200);
anti-collagenIV (Chemicon, AB756P; 1:100) followed by
goat anti-abbit IgG H+L secondary antibody (Alexa Fluor-
488, Molecular Probes; 1:500) and mounted with
Vectashield mountant containing DAPI. Images were
acquired using an epifluorescence microscope (Carl
Zeiss). For immunohistochemistry, EBs were fixed in 4%
paraformaldehyde, dehydrated and embedded in paraffin
wax using standard methods. Dewaxed sections were
processed for antigen retrieval by boiling for 20 min in
Dako antigen retrieval solution and washed in PBS-T
(0.02%) for 10 min. Slides were blocked with either 5%
skimmed milk or 5% goat serum for 1 hour, then incu-
bated with primary antibody overnight at 4°C at 1:400
dilution. Antibodies included anti-laminin, anti-colla-
genIV (as before) and anti-Dab2 (BD Transduction
610464). Sections were washed three times in PBS-T for 5
min. Blocking of endogenous peroxidase, incubation with
peroxidase-labelled polymer and detection with DAB +
chromagen were performed according to the manufac-
turer's instructions (DAKO kit). Sections were counter-
stained with haematoxylin using standard methods.
Basement membrane staining and whole-mount in situ 
hybridisation analysis of embryos
E6.5 embryos were fixed in 4% PFA/PBS, washed in 0.1%
TritonX/PBS and permeabilised in 0.5% TritonX/PBS. Fol-
lowing three washes in 0.1% TritonX/PBS, embryos were
blocked in 5% FBS, 0.2% BSA, 0.1% TritonX - PBS and
incubated overnight in primary rabbit polyclonal anti-
Collagen IV (Chemicon AB756; 1:100). Embryos were
washed extensively with 0.1% TritonX/PBS and then incu-
bated in anti-rabbit Alexa-Fluor 488 secondary antibody
(Invitrogen A11034; 1:200). Embryos were further
washed extensively with 0.1%TritonX/PBS, immersed in
Vectashield mounting media containing DAPI and
imaged using laser scanning confocal microscopy (Zeiss
LSM 710 confocal microscope). Whole mount in situ
hybridisation was performed according to standard proce-
dures [88] using a probe for Oct4 [5]. The experimental
protocols described in this report have been approved by
the Ethical Review Committee of the University of
Oxford.
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